Shares of Precigen, Inc. (NASDAQ:PGEN – Get Free Report) have been given a consensus rating of “Moderate Buy” by the five ratings firms that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating and four have given a buy rating to the company. The average twelve-month target […]